St. Jude Medical (STJ) Reports In-Line Q2 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/3/2026
- Equities close higher as softer jobs data quiets rate-hike expectations
- U.S. economy adds fewer jobs than expected as unemployment rate ticks higher
- Nvidia returns as Morgan Stanley’s Top Pick on attractive valuation
- Citi says rate volatility without Fed repricing is concerning
- U.S. credit-reporting stocks fall as FHFA weighs two-bureau mortgage rule
- Cantor Fitzgerald on Rivian (RIVN): 'pre-announced that it delivered 19,248 vehicles in 3Q26, above our estimate'
- Equities close higher as softer jobs data quiets rate-hike expectations
- DISH DBS emerges from bankruptcy, cuts debt by $4.35 billion
- Tanker struck by projectile in Strait of Hormuz
- AppLovin shares fall after court denies request against Unity
St. Jude Medical Reports Second Quarter 2016 Results
July 20, 2016 7:15 AM EDTST. PAUL, Minn.--(BUSINESS WIRE)-- St. Jude Medical, Inc. (NYSE: STJ), a global medical device company, today reported sales and net earnings for the second quarter ended July 2, 2016.
Second quarter 2016 highlights:
Net sales of $1.562 billion increased 11 percent as reported, or 2 percent on a comparable constant currency basis. International sales increased 10 percent as reported, or 7 percent on a comparable constant currency basis where a full portfolio of products is available. Neuromodulation sales increased 19 percent as reported, or 20 percent on a constant currency... More